Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention

Background: Despite observable improvement in the treatment outcomes of patients with Prader-Willi syndrome (PWS), adequate weight control is still a clinical problem. Therefore, the aim of this study was to analyze the profiles of neuroendocrine peptides regulating appetite—mainly nesfatin-1 and sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajewska, Joanna, Szamotulska, Katarzyna, Klemarczyk, Witold, Chełchowska, Magdalena, Strucińska, Małgorzata, Ambroszkiewicz, Jadwiga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005720/
https://www.ncbi.nlm.nih.gov/pubmed/36904239
http://dx.doi.org/10.3390/nu15051240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005720/
https://www.ncbi.nlm.nih.gov/pubmed/36904239
http://dx.doi.org/10.3390/nu15051240

Ejemplares similares